Related Experiment Video
Updated: May 23, 2026
08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Genetics and genomics in pediatric septic shock
1Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. hector.wong@cchmc.org
Critical Care Medicine
|April 19, 2012
Summary
Genetic and genomic studies reveal key biomarkers and potential therapies for pediatric septic shock. Research highlights gene variations linked to sepsis susceptibility and outcomes, offering hope for improved treatment strategies.
Area of Science:
- Genomics and Genetics
- Pediatric Critical Care
- Infectious Diseases
Background:
- Pediatric septic shock remains a significant public health concern.
- Genetic and genomic approaches are crucial for understanding sepsis.
- Identifying novel pathways and therapeutic targets is essential.
Purpose of the Study:
- To review gene association and genome-wide expression profiling studies in pediatric sepsis.
- To highlight findings related to biomarkers and therapeutic targets.
- To explore genetic subclassification of pediatric septic shock.
Main Methods:
- Literature review of published studies.
- Focus on gene association and expression profiling in pediatric sepsis.
- Analysis of studies on meningococcemia and related genetic factors.
Main Results:
- Gene polymorphisms in inflammation, immunity, and coagulation are associated with sepsis susceptibility and outcomes.
- A functional polymorphism in the plasminogen activator inhibitor-1 promoter is strongly linked to meningococcal sepsis.
- Expression profiling identified zinc supplementation and MMP-8 inhibition as potential therapies.
- Interleukin-8 is a robust outcome biomarker for pediatric septic shock.
Conclusions:
- Genetic and genomic research is advancing the understanding of pediatric sepsis and septic shock.
- These approaches promise to improve future clinical management.
- Gene expression-based subclassification shows clinical relevance.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...